Hepatitis B Virus (HBV) Quantitative PCR Test in Dubai | 800 AED | DNA Labs UAE

Executive Summary & Core Metrics

Test Overview & Methodology

The Hepatitis B Viral Load (HBV DNA) quantitative PCR test measures the exact number of HBV particles in blood, enabling precise monitoring of chronic infection and antiviral treatment efficacy. This test is essential for determining viral replication activity, guiding therapy decisions, and detecting early drug resistance.

Comparative Analysis: Quantitative qPCR vs. Alternative Methods

Feature	Our Test (Quantitative qPCR)	Closest Alternative (Qualitative / Serology)
Methodology	Real-Time PCR (qPCR) with automated nucleic acid extraction and internal amplification control	Qualitative PCR or HBsAg immunoassay
Diagnostic Precision	99.9% sensitivity, LOD 10 IU/mL, broad dynamic range 10 – 1×10⁸ IU/mL	Lower sensitivity, no viral load quantification
Turnaround Time	7 calendar days for comprehensive quantitative result	3–5 days (qualitative) / 1–2 days (serology)
Clinical Utility	Therapy initiation, response monitoring, drug resistance detection, prognosis assessment	Screening only, cannot monitor viral load changes

Pre‑test note: A doctor’s prescription is required. Prescription exemption applies for pre‑surgical clearance, pregnancy screening, and travel‑related medical examinations.

Physician Insight & Safety Protocols

Clinical Note from Dr. Ajay Singh (General Practitioner, DHA Registration ID: 36234132) –

“A single HBV DNA result must always be interpreted in the full clinical context — including liver enzymes, imaging, and symptom history. Patients should never modify or discontinue antiviral therapy without direct specialist supervision. Our commitment is to provide clear, evidence-based guidance throughout your diagnostic journey.”

Safety Exclusion & Emergency Red Flags

Exclusion Criteria (Do Not Proceed Without Physician Clearance)

Active significant bleeding disorder or severe thrombocytopenia (platelets <50,000/µL).
Unstable hemodynamic status or acute severe anemia requiring transfusion support.
Inability to provide informed consent from patient or legal guardian.

ER Red Flags (Seek Immediate Medical Attention)

Acute confusion, asterixis, or progressive jaundice suggestive of hepatic encephalopathy.
Hematemesis or melena with abdominal distension indicating possible variceal bleeding.
Sudden severe right upper quadrant pain with high viral load and fever.

Medication Advisory

⚠️ Do not discontinue or alter any prescribed antiviral medication (e.g., tenofovir, entecavir, pegylated interferon) without explicit instruction from your treating physician. Abrupt cessation of antiviral therapy can precipitate severe hepatitis flares and hepatic decompensation.

Patient FAQ & Clinical Guidance

1. What is the purpose of HBV Quantitative PCR, and when is it recommended?

HBV Quantitative PCR measures viral DNA in blood to diagnose active hepatitis B, monitor chronic infection, and assess antiviral treatment response. It is recommended at baseline before starting therapy, at week 12 and 24 during treatment, and annually for chronic inactive carriers. This test distinguishes between active viral replication and immune clearance phases, guiding therapeutic decisions.

2. How should I prepare for the blood draw, and are there any dietary restrictions?

No fasting is required; however, inform the phlebotomist about all medications, especially anticoagulants like warfarin or apixaban, to minimize hematoma risk. You may eat and drink normally before collection. A prescription is mandatory unless you qualify for exemption categories including pre‑surgical clearance, pregnancy screening, or travel‑related examinations.

3. When will I receive my results, and how will the report be explained?

Results are delivered within 7 working days via secure email. The report includes HBV DNA level in IU/mL, reference range, and a trend graph if previous results exist. A complimentary 15‑minute tele‑consultation with a clinical advisor is available for result interpretation. Critical values are flagged for immediate physician notification.

4. What does the HBV DNA level indicate, and how is it interpreted?

Viral load is reported in IU/mL. Levels above 2,000 IU/mL typically indicate active replication requiring treatment consideration, while levels below 2,000 IU/mL with normal liver enzymes suggest inactive carrier state. Trends over multiple tests provide the most clinically meaningful information for treatment response assessment.

5. Can this test detect drug resistance, and how does that affect treatment?

While standard quantitative PCR monitors viral load changes, a rising viral load during therapy may indicate developing drug resistance. In such cases, additional resistance genotyping may be recommended by your specialist to guide alternative antiviral selection. Our laboratory supports reflex testing for resistance mutations upon physician request.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance & Data Protection Framework

This laboratory service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the processing of personal health information and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for digital health data management. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory procedures adhere to ISO 15189 standards for medical laboratory quality and competence. Patient data is encrypted, access‑controlled, and processed exclusively within secure UAE‑based infrastructure.

Clinical & Logistical Metadata

Test Name	Hepatitis B Virus (HBV) Quantitative PCR – Viral Load
Price (AED)	800 AED
Turnaround Time	7 calendar days from sample collection
Sample Type / Matrix	Peripheral whole blood (plasma separation preferred) – EDTA tube
Methodology Used	Real-Time Quantitative PCR (qPCR) with automated nucleic acid extraction and internal amplification control
ICD-10-CM Code	B18.1 (Chronic viral hepatitis B without delta-agent), B16.9 (Acute hepatitis B without delta-agent and without hepatic coma)
LOINC Code	42595-9 (Hepatitis B virus DNA [log IU/mL] in Blood by NAA with probe detection)
DHA Facility License & Laboratory Address	DHA License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians